-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Testicular Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Testicular Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Testicular Cancer Drug Details: AGENT-797 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Esophageal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Esophageal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Esophageal Cancer Drug Details: AGENT-797 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Prostate Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Prostate Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Prostate Cancer Drug Details: AGENT-797 is under development for...
-
Product Insights
Innovations in Iron Contrast Agents – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Iron Contrast Agents - Global Pipeline Summary" provides comprehensive information about the Iron Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Iron Contrast Agents report provides key information and data related to: Extensive coverage of the Iron Contrast Agents under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Product Insights
Innovations in Manganese Contrast Agents – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Manganese Contrast Agents - Global Pipeline Summary" provides comprehensive information about the Manganese Contrast Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Manganese Contrast Agents report provides key information and data related to: Extensive coverage of the Manganese Contrast Agents under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Product Insights
Innovations in PET Imaging Agents – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in PET Imaging Agents - Global Pipeline Summary" provides comprehensive information about the PET Imaging Agents pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The PET Imaging Agents report provides key information and data related to: Extensive coverage of the PET Imaging Agents under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Refractory Multiple Myeloma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Refractory Multiple Myeloma Drug Details: AGENT-797 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AGENT-797 in Adenocarcinoma Of The Gastroesophageal Junction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AGENT-797 in Adenocarcinoma Of The Gastroesophageal Junction report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AGENT-797 in Adenocarcinoma Of The Gastroesophageal Junction Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-fibrotic Agent in Kidney Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-fibrotic Agent in Kidney Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-fibrotic Agent in Kidney Fibrosis Drug Details: The drug candidate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anti-fibrotic Agent in Myocardial Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-fibrotic Agent in Myocardial Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-fibrotic Agent in Myocardial Fibrosis Drug Details: The drug candidate...